Hernández-Valencia, J.; GarcÃa-Villarreal, R.; RodrÃguez-Jiménez, M.; Hernández-Avalos, A.D.; Rivero, I.A.; Vique-Sánchez, J.L.; Chimal-Vega, B.; Pulido-Capiz, A.; GarcÃa-González, V.
Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone. Int. J. Mol. Sci. 2025, 26, 3763.
https://doi.org/10.3390/ijms26083763
AMA Style
Hernández-Valencia J, GarcÃa-Villarreal R, RodrÃguez-Jiménez M, Hernández-Avalos AD, Rivero IA, Vique-Sánchez JL, Chimal-Vega B, Pulido-Capiz A, GarcÃa-González V.
Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone. International Journal of Molecular Sciences. 2025; 26(8):3763.
https://doi.org/10.3390/ijms26083763
Chicago/Turabian Style
Hernández-Valencia, Jorge, Ruth GarcÃa-Villarreal, Manuel RodrÃguez-Jiménez, Alex Daniel Hernández-Avalos, Ignacio A. Rivero, José Luis Vique-Sánchez, Brenda Chimal-Vega, Angel Pulido-Capiz, and Victor GarcÃa-González.
2025. "Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone" International Journal of Molecular Sciences 26, no. 8: 3763.
https://doi.org/10.3390/ijms26083763
APA Style
Hernández-Valencia, J., GarcÃa-Villarreal, R., RodrÃguez-Jiménez, M., Hernández-Avalos, A. D., Rivero, I. A., Vique-Sánchez, J. L., Chimal-Vega, B., Pulido-Capiz, A., & GarcÃa-González, V.
(2025). Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone. International Journal of Molecular Sciences, 26(8), 3763.
https://doi.org/10.3390/ijms26083763
